Alyeska Investment Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,593,277
| Closed | -$559K | – | 616 |
|
|
2016
Q3 | $559K | Hold |
1,593,277
| – | – | 0.01% | 429 |
|
|
2016
Q2 | $743K | Hold |
1,593,277
| – | – | 0.01% | 397 |
|
|
2016
Q1 | $2.17M | Hold |
1,593,277
| – | – | 0.02% | 323 |
|
|
2015
Q4 | $2.34M | Hold |
1,593,277
| – | – | 0.02% | 295 |
|
|
2015
Q3 | $2.52M | Hold |
1,593,277
| – | – | 0.03% | 319 |
|
|
2015
Q2 | $2.71M | Hold |
1,593,277
| – | – | 0.03% | 325 |
|
|
2015
Q1 | $2.21M | Buy |
1,593,277
+1,063,277
| +201% | +$1.48M | 0.03% | 361 |
|
|
2014
Q4 | $801K | Hold |
530,000
| – | – | 0.01% | 412 |
|
|
2014
Q3 | $1.09M | Hold |
530,000
| – | – | 0.02% | 320 |
|
|
2014
Q2 | $1.62M | Hold |
530,000
| – | – | 0.04% | 323 |
|
|
2014
Q1 | $1.95M | Sell |
530,000
-250,000
| -32% | -$920K | 0.05% | 264 |
|
|
2013
Q4 | $3.87M | Hold |
780,000
| – | – | 0.15% | 184 |
|
|
2013
Q3 | $1.78M | Buy |
780,000
+280,000
| +56% | +$638K | 0.07% | 233 |
|
|
2013
Q2 | $1.11M | Buy |
+500,000
| New | +$1.11M | 0.05% | 234 |
|
Alyeska Investment Group's RXII Position: Q2 2015 in Review
Alyeska Investment Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2015, closing a stake of 485,917 shares — an estimated $675K sold.
Alyeska Investment Group first reported a position in RXII in Q1 2015 and held it in 1 quarter. The position peaked at $675K in Q1 2015. 86 funds tracked by Wall St. Rank hold RXII as of Q2 2015.
- Alyeska Investment Group reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2015 after selling out during the quarter.
- Alyeska Investment Group sold 485,917 GALENA BIOPHARMA INC COM shares in Q2 2015, an estimated $675K.
- Alyeska Investment Group first reported a position in GALENA BIOPHARMA INC COM in Q1 2015 and held it in 1 quarter.
- Alyeska Investment Group's GALENA BIOPHARMA INC COM position peaked at $675K in Q1 2015.
- 86 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2015.
Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.